As the GDPR deadline approaches we cannot forget how important Cybersecurity is. It is important to protect your company and your patients from Cyber criminals. This article from Fierce Biotech highlights the vulnerability that can occur when using medical devices. https://www.fiercebiotech.com/medtech/dhs-warns-cybersecurity-weakness-medtronic-s-neurostimulator-programmer?mkt_tok=eyJpIjoiTnpRMFltUTJZemM0TURrdyIsInQiOiI4K1VDNmUySEFQRzE3SzZQNEd4bENIc2hBUWpaUkZFTmpUVkZnUzQ5QzlvSFZ0N0h4YzZHQUhXXC9xQmhyWHNcL1lVeW9nbTRSekI5WWlrKzhkSUNYcTFUMjNiU3FPVWUyV091VUhqR05RVFd0bm9aV0E1QVZOaGQ2XC8yV0lsT3IyeSJ9&mrkid=64593462
Great article from Springer Nature on the current CAR-T therapies in development. https://lnkd.in/g6r-CRH Do you know Karma Oncology has experience in CAR-T and autologous therapy? Meet us at #ASCO or #BIO to find out more!
CAR-T therapy is making great advances in the oncology market but there are still questions to be answered on the variability of responders. This article gives some insight into the variability of this novel treatment. http://www.philly.com/philly/health/penn-study-points-to-why-t-cell-therapy-fails-in-some-patients-20180430.html?__vfz=medium%3Dsharebar
One of the hottest topics in Immuno-oncology therapy is CAR-T Therapy. This is a fantastic video showcasing how this innovative therapy works to target cancer. Do you know Karma Oncology Ltd. has experience and knowledge in both autologous therapy and CAR-T therapy? We would be delighted to help advance such novel treatments in the oncology
Thanks to Capeia for this interesting article on how the gut microbiome can affect cancer immunotherapy in patients. Everything is connected. We need to follow our gut! Link to article below. https://beta.capeia.com/cancer/2018/04/23/immunotherapy-and-the-microbiome-its-time-to-follow-our-guts
Karma Oncology had a great time at AACR 2018 in Chicago where we covered everything from cancer immunotherapy treatments to cancer patient care to networking. One of the hot topics was how to get a longer lasting response from treatments such as checkpoint inhibitors. Here is a link to one of the interesting articles in
Following on from the fantastic advances witnessed in immunotherapy and cancer treatment at AACR 2018 in Chicago, here is a video from Nature explaining Tumour Immunology and immunotherapy treatment.
The hot topic for Cancer therapy at the moment is Immunotherapy, a treatment that involves using the patient’s own immune system to help fight the battle against cancer. One of the most novel and highly powerful forms of immunotherapy rapidly developing in the field of oncology research at the moment is CAR (chimeric antigen receptor)
Link to an interesting article on the current situation between Big pharma and CROs (Contract Research organization) and the trends and demands for outsourcing work. A few other key messages from responders show that 81% of responders would be more likely to work with an experienced CRO that offers innovative patient recruitment. This is something
Our leadership team is attending this year’s annual AACR Meeting in Chicago from 14th – 18th April. Karma Oncology understands how vital it is to keep up to date with the dynamic scientific advances in the field of cancer and how integral knowledge and learning is to any business or professional within the oncology field.